Key result
Pediatric epicardial lead and generator lifespan remain unaffected by lead type, pacing mode, or age.
Why the study?
Permanent cardiac pacing is uncommon in children and typically achieved through epicardial pacing, but experience and predictors of lead-related complications are not well characterized.
Observational (n=34)
No
In a pediatric cohort, epicardial pacemaker leads demonstrated good longevity that was not significantly affected by lead type, pacing mode, or patient age.
Supports no effect of lead type, mode, or age on pediatric epicardial pacemaker longevity; hypothesis-generating and leaves open need for prospective trials.
Background: Permanent cardiac pacing is uncommon in children, and when performed, it is typically achieved through epicardial pacing. We analysed our clinical group's experience with epicardial pacemaker implantation.Objective: To assess our experience with epicardial pacemakers and to identify potential factors that could predict early and late lead-related complications.Materials and Methods: This study included 34 patients under the age of 12 who underwent implantation of an epicardial pacemaker between 2018 and 2020. A retrospective review of their medical records was conducted. The study was approved by the ethics committee of the institution. A thorough review of the cardiac surgical and pacemaker databases identified all the paediatric patients who underwent permanent epicardial pacemakers implantation at a tertiary care hospital of Peshawar. Adult patients with an age of were omitted to focus on paediatric cohort. Medical records were retrospectively studied.Results: For each patient, the average age across all PPM implantations, including any repeat procedures, was 7.2 ± 2.6 years. The average weight at the time of lead implantation was 24.8±4.0kg. The majority of patients who underwent pacemaker implantation or lead replacement surgery were discharged from the hospital within a week of the procedure. Of all the patients, 36.8% required a pacemaker due to post-op atrioventricular block, 28% had sinus node dysfunction, 20% had congenital complete heart block, and approximately 15.2% of the patients required a pacemaker for other reasons, including bradycardia caused by antiarrhythmic medication.Conclusion: The leads exhibited commendable longevity, enduring without significant variations based on their type. Lead and generator lifespan were unaffected by lead type, pacing mode, or patient age.
No takes yet. Share an insight, caveat, or question.
Qazi et al. (2025) conducted an observational in Bradycardia or heart block requiring pacing (n=34). Epicardial pacemaker implantation was evaluated on Lead and generator longevity and complications. In pediatric patients, epicardial pacemaker lead and generator lifespan were unaffected by lead type, pacing mode, or patient age.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: